Cargando…

Comparison of leucine-rich alpha-2-glycoprotein-1 (LRG-1) plasma levels between patients with and without appendicitis, a case–controlled study

Acute appendicitis (AA) is the first cause of emergency surgery. Leucine-Rich Alpha-2-Glycoprotein 1 (LRG1) has been shown to be a potential biomarker in cases of AA in children, but there are conflicting results for its use in adults. The objective of this study is to compare the median plasma valu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lontra, Marcelo Bentancor, Savaris, Ricardo F., Cavazzola, Leandro Totti, Maissiat, Jackson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946883/ https://www.ncbi.nlm.nih.gov/pubmed/33692371 http://dx.doi.org/10.1038/s41598-021-84013-2

Ejemplares similares

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target
por: Javaid, Faiza, et al.
Publicado: (2021)

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients
por: Popova, Anna, et al.
Publicado: (2022)

Serum and Urine Biomarker Leucine-Rich Alpha-2 Glycoprotein 1 Differentiates Pediatric Acute Complicated and Uncomplicated Appendicitis
por: Kakar, Mohit, et al.
Publicado: (2021)

Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
por: Liu, Jian-Jun, et al.
Publicado: (2023)

Diagnostic Utility of Serum Leucine-Rich α-2-Glycoprotein 1 for Acute Appendicitis in Children
por: Tintor, Goran, et al.
Publicado: (2023)

Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway
por: Miao, Youhan, et al.
Publicado: (2022)

Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
por: Zou, Yonghui, et al.
Publicado: (2022)

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease
por: Yanagimachi, Masakatsu, et al.
Publicado: (2021)

Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification
por: Grzesiak, Lucile, et al.
Publicado: (2023)

Leucine-Rich Alpha-2-Glycoprotein as a non-invasive biomarker for pediatric acute appendicitis: a systematic review and meta-analysis
por: Arredondo Montero, Javier, et al.
Publicado: (2023)

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010)

Diagnostic Accuracy of Leucine-Rich α-2-Glycoprotein 1 as a Non-Invasive Salivary Biomarker in Pediatric Appendicitis
por: Tintor, Goran, et al.
Publicado: (2023)

Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
por: Kajimoto, Etsuko, et al.
Publicado: (2020)

Leucine-Rich Alpha-2-Glycoprotein: A Novel Predictor of Diastolic Dysfunction
por: Loch, Alexander, et al.
Publicado: (2023)

Correction to: Leucine-Rich Alpha-2-Glycoprotein as a non-invasive biomarker for pediatric acute appendicitis: a systematic review and meta-analysis
por: Montero, Javier Arredondo, et al.
Publicado: (2023)

Leucine-Rich Alpha-2-Glycoprotein1 Gene Interferes with Regulation of Apoptosis in Leukemia KASUMI-1 Cells
por: Xiao, Shishan, et al.
Publicado: (2018)

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter
por: Zhang, Qian, et al.
Publicado: (2018)

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma
por: Honda, Hiromi, et al.
Publicado: (2016)

Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis
por: Fujimoto, Minoru, et al.
Publicado: (2020)

Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
por: Umezawa, Natsuka, et al.
Publicado: (2023)

ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand
por: Weivoda, Starchild, et al.
Publicado: (2008)

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
por: Shinzaki, Shinichiro, et al.
Publicado: (2017)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
por: Yasutomi, Eriko, et al.
Publicado: (2021)

Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation
por: Yang, Jimin, et al.
Publicado: (2023)

Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker
por: Shinozaki, Eiji, et al.
Publicado: (2018)

Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2022)

Abstract: Abdominal Dermis Tensile Strength in Aesthetic and Massive Weight-Loss Patients and Its Role in Ventral Hernia Repair: A Cross-Sectional Study
por: Barreiro, Guilherme, et al.
Publicado: (2016)

Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Disease Activity Biomarker in Patients with Rheumatoid Arthritis
por: Ha, You Jung, et al.
Publicado: (2014)

Gene expression of leucine-rich alpha-2 glycoprotein in the polypoid lesion of inflammatory colorectal polyps in miniature dachshunds
por: OHTA, Hiroshi, et al.
Publicado: (2020)

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease
por: Yoshimura, Tetsuhiro, et al.
Publicado: (2021)

Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
por: Otsuru, Toru, et al.
Publicado: (2019)

Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis
por: Yang, Yi, et al.
Publicado: (2020)

The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury
por: Ma, Hong, et al.
Publicado: (2021)

Optimal Use of Serum Leucine-Rich Alpha-2 Glycoprotein as a Biomarker for Small Bowel Lesions of Crohn’s Disease
por: Asonuma, Kunio, et al.
Publicado: (2023)

Monitoring of leucine‐rich alpha‐2‐glycoprotein and assessment by small bowel capsule endoscopy are prognostic for Crohn's disease patients
por: Ito, Takahiro, et al.
Publicado: (2023)

LRG1: an emerging player in disease pathogenesis
por: Camilli, Carlotta, et al.
Publicado: (2022)

Upregulation of leucine-rich alpha-2 glycoprotein: A key regulator of inflammation and joint fibrosis in patients with severe knee osteoarthritis
por: Sarkar, Ashish, et al.
Publicado: (2022)

Usefulness of Serum Leucine-Rich Alpha-2 Glycoprotein as a Surrogate Marker of Small Bowel Mucosal Injury in Crohn’s Disease
por: Saiki, Takuto, et al.
Publicado: (2023)

Usefulness of Serum Leucine-rich Alpha 2 Glycoprotein in Crohn’s Disease: Is There Any Difference between Small Intestine and Colonic Lesions?
por: Matsumoto, Satohiro, et al.
Publicado: (2023)

Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis
por: Kono, Masashi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aioard4cvcusggrg36q849ksl8